1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

NodThera Limited

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2016

Location

Cambridge UK

Primary Industry

Biotechnology

About

Founded in 2016 and based in Cambridge, UK, NodThera Limited operates as a developer of NRLP3, an inflammasome activation inhibitors for the treatment of chronic inflammation.
Current Investors
Sofinnova Partners, 5AM Ventures, F-Prime Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.nodthera.com
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.